tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

EPX Limited Reports Growth in ACV and ARR for Q3 2025

Story Highlights
EPX Limited Reports Growth in ACV and ARR for Q3 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from EPX ( (AU:EPX) ) is now available.

EPX Limited, a company listed on the Australian Securities Exchange, reported a net increase in its Annual Contract Value (ACV) to $18.0 million for the quarter ending September 2025, despite a $0.4 million reduction due to a court settlement with a nonperforming UAE customer. The company also saw its Annual Recurring Revenue (ARR) rise to $15.7 million, with site numbers growing to 759, indicating steady operational growth and expansion in both the UAE and Australia. The announcement highlights EPX’s strategic wins, including a significant partnership with a leading UAE healthcare organization and new contracts in the Australian property development sector, positioning the company for continued growth in its market.

The most recent analyst rating on (AU:EPX) stock is a Buy with a A$0.04 price target. To see the full list of analyst forecasts on EPX stock, see the AU:EPX Stock Forecast page.

More about EPX

Average Trading Volume: 558,501

Technical Sentiment Signal: Buy

Learn more about EPX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1